Table II.
Patient Characteristics by NLR <5 and ≥5*.
| All Patients N=432 |
NLR <5 N=360 |
NLR ≥5 N=72 |
P† | |
|---|---|---|---|---|
| Age >75 | 28.2% | 28.1% | 29.2% | 0.85 |
| Sex, male | 64.1% | 64.7% | 61.1% | 0.56 |
| BMI, kg/m2 | 26.9±4.5 | 27.2±4.6 | 25.7±3.5 | 0.01 |
| Years of Education | 14.5±3.4 | 14.6±3.6 | 14.3±2.6 | 0.54 |
| History of Smoking | 67.8% | 69.7% | 58.3% | 0.06 |
| Statin Use | 57.4% | 62.8% | 30.6% | <0.001 |
| Hypertension | 53.5% | 55.3% | 44.4% | 0.09 |
| Diabetes Mellitus | 20.6% | 21.4% | 16.7% | 0.36 |
| PVD | 28.6% | 29.0% | 26.9% | 0.73 |
| Symptomatic Status | 39.4% | 38.6% | 43.1% | 0.48 |
| Cross Clamp Duration, mins | 42.9±17.1 | 43.0±1.0 | 42.2±2.1 | 0.71 |
| NLR | 3.4±2.9 | 2.4±1.0 | 8.0±4.6 | <0.001 |
| Cognitive Dysfunction | 24.3% | 12.8% | 34.7% | <0.001 |
*
Mean ± standard deviation; BMI – body mass index, PVD – peripheral vascular disease, NLR – neutrophil-lymphocyte ratio
†
P values of univariate comparisons of the characteristic between patients with NLR <5 and ≥5